바이오인

In 2011, the German biotechnology industry continued its moderate growth of recent years. This is underlined by higher revenues of 2.6 billion euros (+10%) and an increase in the number of employees to around 16,300 (+5.3%) in dedicated biotechnology firms. The number of dedicated biotechnology firms also rose (+2.6%). Research and development costs came to just under a billion euros in 2011 (-4%). Securing financing represented a major challenge for most biotechnology companies − a very low sum of just 142 million euros was invested in the sector over the course of the year.